Scribe Therapeutics Inc SCTX

$18.41 -4.63 (-20.08%)

Valuation

Market cap
412,149,000
Revenue TTM
$51,174,000
Net income TTM
$-21,808,000
PE ratio
0.00
Forward PE
—
Profit margin
-42.62%
Debt to equity
0.00

Trading

Volume
1,180,084
Avg volume
—
Day's range
$17.69 – $23.40
Shares out
18,932,000
Stochastic %K
19%
Beta
—
Analysts
Strong Sell
Price target
$57.00

Price

Company profile

Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene...

Show more

Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.

Industry
Biotechnology
Sector
Healthcare
Phone
510 626 8587
Website
https://www.scribetx.com
Address
1150 Marina Village Pkwy, Alameda, United States

Latest news

Stocktwits

Conncort Sep 30, 6:09 PM
$SCTX -Cathy Woods will be averaging in here🎯👊🏻💰💰
0 replies
CDMO Sep 30, 5:28 PM
$SCTX oh 🤪
0 replies
slappydoo Sep 30, 5:02 PM
$SCTX rip scribe LOL. thing only been active for like a month and its already cooked.
0 replies
titanmaximum2 Sep 30, 4:17 PM
$SCTX A bloodbath.
2 replies
CDMO Sep 24, 6:35 PM
$SCTX whut
0 replies
HaremBee Sep 24, 4:33 PM
$SCTX holy shit balls
0 replies
Merlintrader Sep 23, 8:18 PM
Scribe Therapeutics ($SCTX): STX-1150 in Phase 1, First Human Data Guided for H1 2027 Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/scribe-therapeutics-sctx-stock-hub/
0 replies
Getthismoney101 Sep 23, 10:59 AM
$WAFU 2.04 cash per share and no DILLUTION!! $GME $SCTX $FAMI
0 replies